Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia
NCT05913609
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Shoulder Dystocia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- FetalEase Ltd.
- Last updated on ClinicalTrials.gov
- November 25, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- University of Miami - Jackson Memorial · Miami, FL
Idaho · 1
- Rosemark WomenCare Specialist · Idaho Falls, ID
North Carolina · 1
- Unified Women's Clinical Research · Winston-Salem, NC
Virginia · 1
- Inova Fairfax Medical Campus · Falls Church, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.